Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

Figure 1: A schematic diagram that illustrates the steps involved in content generation, processing and data analysis for antigen microarrays. Antigen-specific tolerization with epitopes of oral type ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Samsung is set to transform the foldable smartphone market with the highly anticipated Galaxy Z Fold 8 and Galaxy Widefold. These devices aim to combine innovative technology with practical features, ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Today, Science, Technology, and Innovation are increasingly important in all spheres of human life. As science and technology rapidly advance, some developing nations are seizing the opportunity to ...